Systemic polyarteritis nodosa

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:439762M30.0
Who is this for?
Show terms as
22Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Systemic polyarteritis nodosa (PAN) is a rare disease that causes inflammation and damage to medium-sized blood vessels (arteries) throughout the body. It is also known simply as polyarteritis nodosa or classic polyarteritis nodosa. When blood vessels become inflamed, they can narrow, weaken, or develop small bulges (aneurysms), which reduces blood flow to the organs they supply. This can affect many parts of the body, including the kidneys, skin, nerves, muscles, joints, and digestive system. Common symptoms include fever, weight loss, fatigue, muscle and joint pain, skin rashes or nodules, numbness or tingling in the hands and feet, abdominal pain, and high blood pressure. In some cases, the disease can damage the kidneys, heart, or intestines, which can be life-threatening if not treated promptly. The exact cause of systemic PAN is not fully understood, but it is believed to involve the immune system mistakenly attacking the body's own blood vessels. In some cases, it has been linked to hepatitis B virus infection. Treatment typically involves medications that suppress the immune system, such as corticosteroids (like prednisone) and cyclophosphamide. With early diagnosis and proper treatment, many patients can achieve remission, though relapses can occur. The treatment approach depends on the severity of the disease and which organs are involved.

Also known as:

Key symptoms:

Unexplained feverUnintentional weight lossSevere fatigueMuscle aches and weaknessJoint painSkin nodules or purplish spotsNumbness or tingling in hands and feetAbdominal pain, especially after eatingHigh blood pressureKidney problemsTesticular pain in menSkin ulcers or livedo reticularis (net-like skin discoloration)Nerve pain or weakness in limbsBlood in the urineChest pain or shortness of breath

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Systemic polyarteritis nodosa.

View clinical trials →

No actively recruiting trials found for Systemic polyarteritis nodosa at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Systemic polyarteritis nodosa community →

Specialists

22 foundView all specialists →
PM
Peter A Merkel, MD, MPH
Tampa, Florida
Specialist

Rare Disease Specialist

PI on 7 active trials
RM
Robert Micheletti, MD
PHILADELPHIA, PA
Specialist
PI on 2 active trials
PM
Peter C Grayson, M.D.
BOSTON, MA
Specialist
PI on 2 active trials
AM
Ashish J Mathew
LOS BANOS, CA
Specialist
1 Systemic polyarteritis nodosa publication
JM
John Mathew
Specialist
1 Systemic polyarteritis nodosa publication
MT
Meera Thomas
Specialist
1 Systemic polyarteritis nodosa publication
RG
Ruchika Goel
SPRINGFIELD, IL
Specialist
1 Systemic polyarteritis nodosa publication
JR
Julien Rohmer
Specialist
1 Systemic polyarteritis nodosa publication
YN
Yann Nguyen
Specialist
1 Systemic polyarteritis nodosa publication
AJ
Avanish Jha
Specialist
1 Systemic polyarteritis nodosa publication
CR
Chitra R
Specialist
1 Systemic polyarteritis nodosa publication
BY
Bijesh Yadav
Specialist
1 Systemic polyarteritis nodosa publication
BS
Betty Simon
Specialist
1 Systemic polyarteritis nodosa publication
CA
Christian Agard
Specialist
1 Systemic polyarteritis nodosa publication
LT
Ludovic Trefond
Specialist
1 Systemic polyarteritis nodosa publication
PC
Pierre Charles
Specialist
1 Systemic polyarteritis nodosa publication
JA
Jean Sebastien Allain
Specialist
1 Systemic polyarteritis nodosa publication
AB
Alice Berezne
Specialist
1 Systemic polyarteritis nodosa publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Systemic polyarteritis nodosa.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Systemic polyarteritis nodosaForum →

No community posts yet. Be the first to share your experience with Systemic polyarteritis nodosa.

Start the conversation →

Latest news about Systemic polyarteritis nodosa

No recent news articles for Systemic polyarteritis nodosa.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is my PAN, and which organs are affected?,What treatment plan do you recommend, and what are the side effects I should watch for?,How often will I need blood tests and follow-up visits?,Should I be tested for hepatitis B or other infections before starting treatment?,What are the warning signs that I should go to the emergency room?,Is there a chance my disease could go into remission, and how long might treatment last?,Are there any clinical trials or newer treatments I should consider?

Common questions about Systemic polyarteritis nodosa

What is Systemic polyarteritis nodosa?

Systemic polyarteritis nodosa (PAN) is a rare disease that causes inflammation and damage to medium-sized blood vessels (arteries) throughout the body. It is also known simply as polyarteritis nodosa or classic polyarteritis nodosa. When blood vessels become inflamed, they can narrow, weaken, or develop small bulges (aneurysms), which reduces blood flow to the organs they supply. This can affect many parts of the body, including the kidneys, skin, nerves, muscles, joints, and digestive system. Common symptoms include fever, weight loss, fatigue, muscle and joint pain, skin rashes or nodules,

How is Systemic polyarteritis nodosa inherited?

Systemic polyarteritis nodosa follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Systemic polyarteritis nodosa typically begin?

Typical onset of Systemic polyarteritis nodosa is adult. Age of onset can vary across affected individuals.

Which specialists treat Systemic polyarteritis nodosa?

22 specialists and care centers treating Systemic polyarteritis nodosa are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.